HydRegen Limited
HydRegen delivers renewable, next-generation bio-based manufacturing capabilities that operate within existing chemical manufacturing infrastructure but under more energy and resource-efficient conditions. For one of its case study processes, paracetamol production, HydRegen predicts a 3 x CO2e saving, as well as a safer and more agile manufacturing process that could support more competitive EU-based production and therefore facilitate secure supply chains of this critical chemical product.